HEAD AND NECK CANCER
Clinical trials for HEAD AND NECK CANCER explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCER trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New imaging technique could reduce harsh side effects of throat cancer treatment
Disease control Not yet recruitingThis study is testing whether a special imaging scan called SPECT-CT can help doctors decide whether throat cancer patients need radiation treatment on one side or both sides of their neck. Currently, most patients receive radiation to both sides, which causes more side effects a…
Matched conditions: HEAD AND NECK CANCER
Phase: NA • Sponsor: UNICANCER • Aim: Disease control
Last updated Apr 03, 2026 19:55 UTC
-
New drug duo aims to shrink oral tumors before surgeons operate
Disease control Not yet recruitingThis study is testing whether giving two drugs, XL-092 and pembrolizumab, before surgery can better shrink or eliminate tumors in people with a specific type of oral cavity cancer that is not linked to HPV. The goal is to see if this combination leads to more patients having litt…
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New combo attack on tough head & neck cancers
Disease control Not yet recruitingThis study aims to see if giving radiation therapy (either standard X-ray or proton therapy) along with an immunotherapy drug (pembrolizumab) before surgery is safe and more effective for people whose head and neck cancer has come back. The research will involve about 40 adults w…
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE1, PHASE2 • Sponsor: University of Cincinnati • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Could less radiation mean fewer side effects for throat cancer patients?
Disease control Not yet recruitingThis study is testing whether doctors can safely lower radiation doses for people with HPV-positive throat cancer to reduce side effects while still keeping the cancer under control. It will enroll 132 adults who are having either surgery followed by radiation or radiation as the…
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Trial aims to reduce harsh side effects of cancer radiation
Disease control Not yet recruitingThis study is testing a more personalized approach to radiation therapy given after surgery for head and neck cancer. The goal is to see if doctors can safely target radiation to smaller, specific areas to reduce common and severe side effects, without increasing the risk of the …
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: Olgun Elicin • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug duo aims to stop head & neck Cancer's return
Disease control Not yet recruitingThis study is for adults with HPV-positive head and neck cancer who have finished their main treatment but still have tiny traces of cancer in their blood. It will test if adding a new drug called fianlimab to an existing immunotherapy (cemiplimab) works better than the single dr…
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New drug duo aims to boost immune attack on tough head and neck cancers
Disease control Not yet recruitingThis early-stage study is testing whether adding an experimental drug called decitabine can make an approved immunotherapy (nivolumab) work better against recurrent or spreading head and neck cancer. The main goals are to find the safest dose of the combination and see how it aff…
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE1 • Sponsor: Kyunghee Burkitt, DO, PhD • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New Immune-Boosting combo targets tough head & neck cancers
Disease control Not yet recruitingThis study is testing whether adding an immunotherapy drug called toripalimab to standard chemotherapy is safe and effective for people with a specific type of advanced head and neck cancer. It will involve about 26 adults whose cancer has not spread to distant organs. The main g…
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC
-
Cheaper scan could speed up cancer treatment planning
Diagnosis Not yet recruitingThis study is testing if a type of CT scan called Dual-Energy CT (DECT) can work as well as MRI scans for planning radiation therapy. Doctors need very clear pictures to map out tumors and avoid damaging healthy organs during radiation. The study will enroll 80 patients with canc…
Matched conditions: HEAD AND NECK CANCER
Sponsor: Aalborg University Hospital • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
Can a drug save hearing for cancer patients?
Symptom relief Not yet recruitingThis study is testing if a drug called Pedmark® can protect hearing in adults receiving cisplatin chemotherapy, a common cancer treatment that often causes hearing loss. The drug is already approved for children, but this trial will see if it's safe and effective for adults with …
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE1, PHASE2 • Sponsor: University of Arizona • Aim: Symptom relief
Last updated Apr 03, 2026 14:42 UTC
-
Simple skin dressings battle painful radiation burns in cancer patients
Symptom relief Not yet recruitingThis study aims to find the best way to prevent or reduce severe skin rashes in people receiving radiation therapy for head and neck cancer. Researchers will compare two different, easy-to-use skin dressings on 104 patients undergoing a specific type of radiation called TomoThera…
Matched conditions: HEAD AND NECK CANCER
Phase: NA • Sponsor: King Faisal Specialist Hospital & Research Center • Aim: Symptom relief
Last updated Apr 02, 2026 14:56 UTC
-
Nurses take charge to keep cancer patients on track for treatment
Symptom relief Not yet recruitingThis study is testing whether a proactive, nurse-led program to manage symptoms can help people with head and neck cancer complete their planned radiation therapy without unplanned breaks. It will compare this new approach to standard care in 170 patients. The main goal is to see…
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE3 • Sponsor: West China Hospital • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC
-
Dental visits aim to ease cancer Survivors' pain and improve life
Symptom relief Not yet recruitingThis study is testing whether a special dental care program can help people who have survived head and neck cancer. It will see if regular visits to a dental hygienist every three months can reduce long-term mouth problems like dry mouth, pain, and tooth decay, and improve qualit…
Matched conditions: HEAD AND NECK CANCER
Phase: NA • Sponsor: Uppsala University • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC
-
Spray-On skin cells aim for better color match after facial surgery
Symptom relief Not yet recruitingThis study is testing if a new technique using a patient's own skin cells (RECELL®) can lead to a better skin color match after reconstructive surgery for head and neck cancer. Researchers will compare the new method to two standard skin grafting techniques in 20 patients. The ma…
Matched conditions: HEAD AND NECK CANCER
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Mar 23, 2026 15:18 UTC
-
Can custom facial prostheses restore eating and smiling after cancer?
Symptom relief Not yet recruitingThis study follows head and neck cancer survivors who receive custom facial prostheses to restore their appearance and function. Researchers will measure how well patients can chew, swallow, and speak before and after getting their prosthesis, and track changes in their quality o…
Matched conditions: HEAD AND NECK CANCER
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Mar 23, 2026 15:16 UTC